|

Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?

RECRUITINGN/ASponsored by University of Vienna
Actively Recruiting
PhaseN/A
SponsorUniversity of Vienna
Started2025-11-05
Est. completion2027-05
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07418450

Summary

During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Pulmonary lesion suspicious for lung cancer or histologically confirmed lung cancer
* indication for mediastinal staging

Exclusion Criteria:

\-

Conditions3

CancerLung CancerLung Cancer (Diagnosis)

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.